| (-)-11-Hydroxy-Δ8-tetrahydrocannabivarin |
|
|
|
| (-)-6α-Hydroxy cannabidiol |
|
|
99.0% |
| (-)-7-Nor-7-carboxy cannabidiol |
|
|
|
| (E)-RNB-61 |
|
|
|
| (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide |
|
|
|
| (R)-JD-5037 |
|
|
|
| (R)-Methanandamide |
|
|
|
| (R)-Monlunabant |
|
|
98.16% |
| (R)-SLV 319 |
|
|
|
| (R)-Zevaquenabant |
|
|
99.15% |
| (Rac)-Zevaquenabant |
|
|
99.20% |
| (±)-6',7'-Dihydroxy cannabichromene |
|
|
|
| (±)-6',7'-Epoxy cannabichromene |
|
|
|
| (±)-8'-Hydroxy cannabichromene |
|
|
|
| (±)-9-Nor-9α-hydroxy Hexahydrocannabinol |
|
|
|
| (±)-9-Nor-9β-hydroxy Hexahydrocannabinol |
|
|
|
| (±)-9α-Hydroxy hexahydrocannabinol |
|
|
|
| (±)-Cannabichromebutolic acid |
|
|
|
| (±)-Cannabichromeorcin |
|
|
|
| (±)-CBCP |
|
|
|
| (±)-Ibipinabant |
|
|
99.30% |
| (±)5(6)-EET Ethanolamide |
|
|
|
| 1'-Naphthoyl-2-methylindole |
|
|
|
| 1-(1-Methyl-1H-indol-3-yl)-2-(1-naphthalenyl)ethanone |
|
|
|
| 2-(1-(4-Fluorobenzyl)-1H-indol-3-yl)acetic acid |
|
|
|
| 10(R)-Hydroxy-9(S)-hexahydrocannabinol |
|
|
99.9% |
| 10(S)-Hydroxy-9(R)-hexahydrocannabinol |
|
|
|
| 10α-Hydroxy-exo-THC |
|
|
|
| 10α-Hydroxy-Δ8-THC |
|
|
|
| 11(Z),14(Z)-Eicosadienoic acid ethanolamide |
|
|
|
| 11-Hydroxy-9(R)-hexahydrocannabinol |
|
|
|
| 11-Hydroxy-9(S)-hexahydrocannabinol |
|
|
|
| 11-Nor-9(R)-carboxy-hexahydrocannabinol |
|
|
|
| 11-Nor-9(S)-carboxy-hexahydrocannabinol |
|
|
|
| 15(S)-HETE Ethanolamide |
|
|
|
| (1H-Indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
|
|
99.99% |
| 2-(2-Chlorophenyl)-1-(1H-indol-3-yl)ethanone |
|
|
|
| 2-Arachidonoylglycerol |
|
|
99.92% |
| 2-Arachidonoylglycerol-d11 |
|
|
|
| 2-Arachidonoylglycerol-d5 |
|
|
99.9% |
| 2-Arachidonoylglycerol-d8 |
|
|
98.5% |
| 2-Fluoro QMPSB |
|
|
|
| 2-Linoleoyl glycerol |
|
|
99.9% |
| 2-Linoleoyl glycerol-d5 |
|
|
|
| 2-Palmitoylglycerol |
|
|
99.0% |
| 5-Heptylresorcinol |
|
|
|
| 3-CAF |
|
|
|
| 5'-Hydroxy-9(R)-hexahydrocannabinol |
|
|
|
| 5'-Hydroxy-9(S)-hexahydrocannabinol |
|
|
|
| 5-Fluoro PB-22 3-carboxyindole metabolite |
|
|
|
| 5-Fluoro PB-22 5-hydroxyquinoline isomer |
|
|
|
| 5-Fluoro PB-22 7-hydroxyquinoline isomer |
|
|
|
| 5-Fluoro PB-22 8-hydroxyisoquinoline isomer |
|
|
|
| 5-Fluoro PB-22 N-(2-fluoropentyl) isomer |
|
|
|
| 5-Fluoro THJ |
|
|
|
| 5Br-INACA |
|
|
|
| 5Z,8Z,11Z,14Z-Eicosatetraenoic acid, 3-thienylmethyl ester |
|
|
|
| 6',7'-Epoxy cannabigerol |
|
|
|
| 6α-Oxycodol N-oxide |
|
|
|
| 8(R)-Hydroxy-9(R)-hexahydrocannabinol |
|
|
|
| 8(R)-Hydroxy-9(S)-Hexahydrocannabinol |
|
|
|
| 8(S)-Hydroxy-9(R)-hexahydrocannabinol |
|
|
|
| 8(S)-Hydroxy-9(S)-hexahydrocannabinol |
|
|
|
| 8β-Hydroxy-exo-THC |
|
|
|
| 9β,10β-epoxy Hexahydrocannabinol |
|
|
|
| A-836339 |
|
|
99.84% |
| AB-FUBICA |
|
|
|
| AB-FUBINACA 3-fluorobenzyl isomer |
|
|
|
| AB-MDMSBA |
|
|
|
| ABD459 |
|
|
|
| AChE/BChE-IN-18 |
|
|
|
| ADB-BICA |
|
|
|
| ADB-BINACA |
|
|
|
| ADB-IATA |
|
|
|
| Afubiata |
|
|
|
| AM-6538 |
|
|
99.85% |
| AM11542 |
|
|
|
| AM11638 |
|
|
|
| AM12814 |
|
|
|
| AM251 |
|
|
99.09% |
| AM281 |
|
|
98.60% |
| AM404 |
|
|
99.0% |
| AM404-d4 |
|
|
|
| AM6545 |
|
|
99.32% |
| AM841 |
|
|
|
| AM8936 |
|
|
|
| AM9405 |
|
|
|
| Amauromine |
|
|
|
| Anandamide-d11 |
|
|
99% |
| Anandamide-d8 |
|
|
99.9% |
| ANEB-001 |
|
|
|
| Anti-inflammatory agent 94 |
|
|
|
| APP-FUBINACA |
|
|
|
| Arachidonoyl 2'-fluoroethylamide |
|
|
|
| Arachidonoyl ethanolamide phosphate |
|
|
|
| Arachidonoyl-N,N-dimethyl amide |
|
|
99.9% |
| Arachidonylcyclopropylamide |
|
|
99.9% |
| ARN272 |
|
|
98.36% |
| Arvanil |
|
|
99.1% |
| Auriculasin |
|
|
98.54% |
| AZD-2207 |
|
|
|
| AZD1940 |
|
|
99.58% |
| Azidoindolene 1 |
|
|
|
| b-AEA |
|
|
95.89% |
| BAY 38-7271 |
|
|
|
| Bay 59-3074 |
|
|
98.60% |
| BB-22 |
|
|
|
| BB-223-carboxyindole metabolite |
|
|
|
| BI-5756 |
|
|
|
| BMS-812204 |
|
|
|
| BNS808 |
|
|
|
| BPR-890 |
|
|
|
| BPRCB1184 |
|
|
99.83% |
| BZO-CHMOXIZID |
|
|
|
| Bzo-poxizid |
|
|
|
| Bzo-poxizid-d9 |
|
|
|
| Cannabicyclolic acid |
|
|
|
| Cannabidihexol |
|
|
|
| Cannabidiol monomethyl ether |
|
|
|
| Cannabidiol-C8 |
|
|
|
| Cannabidivarin diacetate |
|
|
|
| Cannabidivarinic acid |
|
|
99.67% |
| Cannabifuran |
|
|
|
| Cannabigerobutolic acid |
|
|
|
| Cannabigerol diacetate |
|
|
|
| Cannabigerolic acid monomethyl ether |
|
|
|
| Cannabigerophorol |
|
|
|
| Cannabigerorcin |
|
|
|
| Cannabigerorcinic acid |
|
|
|
| Cannabigerovarin |
|
|
|
| Cannabigerovarinic acid |
|
|
|
| Cannabinodiol |
|
|
98.31% |
| Cannabinol acetate |
|
|
|
| Cannabinol ethyl |
|
|
|
| Cannabinol methyl ether |
|
|
|
| Cannabiorcol |
|
|
|
| Carmagerol |
|
|
|
| CB-25 |
|
|
98.84% |
| CB-52 |
|
|
|
| CB1 agonist 1 |
|
|
99.84% |
| CB1 antagonist 1 |
|
|
|
| CB1 antagonist 2 |
|
|
99.91% |
| CB1 antagonist 4 |
|
|
98.00% |
| CB1 antagonist 5 |
|
|
98.20% |
| CB1 antagonist 6 |
|
|
|
| CB1 inverse agonist 2 |
|
|
99.15% |
| CB1-IN-2 |
|
|
|
| CB1-IN-3 |
|
|
|
| CB1-receptor agonist-1 |
|
|
|
| CB1/2 agonist 1 |
|
|
98.68% |
| CB1/2 agonist 2 |
|
|
|
| CB1/2 agonist 3 |
|
|
99.27% |
| CB1/2 agonist 4 |
|
|
|
| CB1/2 receptor-1 |
|
|
|
| CB1R agonist 1 |
|
|
|
| CB1R Allosteric modulator 1 |
|
|
|
| CB1R Allosteric modulator 2 |
|
|
|
| CB1R Allosteric modulator 3 |
|
|
98.05% |
| CB1R Allosteric modulator 4 |
|
|
|
| CB1R Allosteric modulator 5 |
|
|
98.35% |
| CB1R antagonist 1 |
|
|
99.89% |
| CB1R antagonist 2 |
|
|
|
| CB1R/AMPK modulator 1 |
|
|
|
| CB2 modulator 1 |
|
|
99.75% |
| CB2 PET Radioligand 1 |
|
|
|
| CB2 receptor agonist 10 |
|
|
99.9% |
| CB2 receptor agonist 2 |
|
|
99.0% |
| CB2 receptor agonist 3 |
|
|
99.86% |
| CB2 receptor agonist 4 |
|
|
|
| CB2 receptor agonist 6 |
|
|
|
| CB2 receptor agonist 7 |
|
|
|
| CB2 receptor agonist 8 |
|
|
|
| CB2 receptor agonist 9 |
|
|
|
| CB2 receptor antagonist 1 |
|
|
|
| CB2 receptor antagonist 2 |
|
|
|
| CB2 receptor antagonist 3 |
|
|
|
| CB2 receptor antagonist 4 |
|
|
|
| CB2 receptor antagonist 5 |
|
|
|
| CB2R agonist 1 |
|
|
|
| CB2R agonist 2 |
|
|
|
| CB2R agonist 3 |
|
|
|
| CB2R agonist 4 |
|
|
|
| CB2R agonist-5 |
|
|
|
| CB2R antagonist 3 |
|
|
98.08% |
| CB2R antagonist 4 |
|
|
|
| CB2R ligand-1 |
|
|
|
| CB2R PAM |
|
|
98.09% |
| CB2R probe 1 |
|
|
|
| CB2R-IN-1 |
|
|
|
| CB2R/5-HT1AR agonist 1 |
|
|
|
| CB2R/FAAH modulator-1 |
|
|
99.14% |
| CB2R/FAAH modulator-2 |
|
|
|
| CB2R/FAAH modulator-3 |
|
|
99.71% |
| CB65 |
|
|
98.94% |
| CBR Agonist-1 |
|
|
|
| CBR Agonist-2 |
|
|
|
| CE-178253 benzenesulfonate |
|
|
|
| CH-FUBIATA |
|
|
|
| CH-PIATA |
|
|
|
| CHM-FUBIATA |
|
|
|
| CHO-4′Me-5′Br-FUBOXPYRA |
|
|
|
| CM304 free base |
|
|
|
| COR170 |
|
|
|
| Dehydrocannabifuran |
|
|
|
| Delta8-THC acetate |
|
|
|
| Dihomo-γ-Linolenoyl Ethanolamide |
|
|
99.9% |
| Docosahexaenoyl glycerol |
|
|
≥99.0% |
| Docosatetraenylethanolamide |
|
|
98.00% |
| Dodec-2E-ene-8,10-diynoic acid isobutylamide |
|
|
|
| Drinabant |
|
|
99.0% |
| EGFR-IN-178 |
|
|
|
| Eicosapentaenoyl ethanolamide |
|
|
98.38% |
| Eicosapentaenoyl ethanolamide-d4 |
|
|
99.0% |
| Epifriedelanol acetate |
|
|
|
| Etrinabdione |
|
|
99.16% |
| exo-Tetrahydrocannabivarin |
|
|
|
| exo-Tetrahydrocannabivarin methyl ether |
|
|
|
| exo-THCP |
|
|
|
| FDU-PB-22 |
|
|
|
| GAT100 |
|
|
|
| GAT211 |
|
|
99.96% |
| GAT228 |
|
|
|
| GAT229 |
|
|
|
| GAT564 |
|
|
|
| Giminabant |
|
|
|
| GP1a |
|
|
99.66% |
| GPX4-IN-18 |
|
|
95.79% |
| GW 833972A |
|
|
99.91% |
| GW 833972A (Standard) |
|
|
|
| GW 833972A free base |
|
|
|
| GW-405833 |
|
|
98.91% |
| GW405833 hydrochloride |
|
|
99.59% |
| GW842166X |
|
|
99.97% |
| hBChE-IN-2 |
|
|
|
| Hemopressin (human, mouse) |
|
|
99.95% |
| Hemopressin(human, mouse) TFA |
|
|
|
| Hemopressin(rat) |
|
|
99.14% |
| Hemopressin(rat) TFA |
|
|
|
| Heptadecanoyl ethanolamide |
|
|
99.0% |
| Hexocannabitriol |
|
|
|
| HU 433 |
|
|
|
| IDFP |
|
|
|
| ISAM-CG557 |
|
|
|
| iso-Hexahydrocannabinol |
|
|
|
| Isopropyl dodec-11-enylfluorophosphonate |
|
|
|
| JD-5037 |
|
|
99.38% |
| JHU-75528 |
|
|
|
| JTE 7-31 |
|
|
|
| JTE-907 |
|
|
98.54% |
| KM-233 |
|
|
|
| L-759656 |
|
|
|
| L759633 |
|
|
99.9% |
| LBP1 |
|
|
|
| Leelamine |
|
|
95.69% |
| LEI-101 |
|
|
99.35% |
| Levonantradol hydrochloride |
|
|
|
| LH21 |
|
|
99.83% |
| Linoleoyl ethanolamide |
|
|
99.98% |
| Linoleoyl ethanolamide-d4 |
|
|
99.15% |
| LY2828360 |
|
|
99.50% |
| LY320135 |
|
|
|
| MDA 19 |
|
|
98.80% |
| MDA-19 N-(5-hydroxyhexyl) |
|
|
|
| MDA7 |
|
|
|
| MDA77 |
|
|
|
| MDMB-FUBICA |
|
|
|
| MDMB-FUBICA metabolite 3 |
|
|
|
| MDMB-FUBINACA metabolite M1 |
|
|
|
| Mead ethanolamide |
|
|
|
| MEP-FUBICA |
|
|
|
| Methyl-1-(cyclohexylmethyl)-1H-indole-3-carboxylate |
|
|
|
| MJ15 |
|
|
99.78% |
| MK-5596 |
|
|
|
| MN-25 |
|
|
|
| Monlunabant |
|
|
99.99% |
| MRL-650 |
|
|
|
| N-(3-Hydroxyphenyl)-arachidonoyl amide |
|
|
|
| N-Arachidonyldopamine |
|
|
98.36% |
| N-Arachidonyldopamine-d8 |
|
|
|
| N-Oleoyl glycine |
|
|
99.0% |
| NAPIE |
|
|
|
| Nervonoyl ethanolamide |
|
|
|
| NESS 0327 |
|
|
99.22% |
| Neuroprotective agent 15 |
|
|
|
| NIDA-41020 |
|
|
|
| Noladin ether |
|
|
|
| Nonabine |
|
|
99.95% |
| O-1269 |
|
|
|
| O-1812 |
|
|
|
| O-2050 |
|
|
|
| O-2093 |
|
|
|
| O-2545 hydrochloride |
|
|
|
| O-7460 |
|
|
95.0% |
| O-Arachidonoyl glycidol |
|
|
|
| O-Arachidonoyl glycidol-d5 |
|
|
|
| O1918 |
|
|
98.71% |
| OLHHA |
|
|
|
| Olorinab |
|
|
99.22% |
| OMDM-6 |
|
|
|
| Org 27569 |
|
|
99.75% |
| ortho-CBNQ |
|
|
|
| Palmitoyl serinol |
|
|
99.89% |
| Palmitoyl serinol-d5 |
|
|
|
| Palmitoylisopropylamide |
|
|
|
| PB-22 N-Pentanoic acid-3-carboxyindole metabolite |
|
|
|
| PF-03550096 |
|
|
|
| PF-514273 |
|
|
|
| PGN36 |
|
|
99.38% |
| Pirnabine |
|
|
|
| PM226 |
|
|
|
| PQM-244 |
|
|
|
| Pregnenolone monosulfate sodium-13C2,d2 |
|
|
|
| Prostaglandin E2-1-glyceryl ester |
|
|
|
| Prostaglandin E2-1-glyceryl ester-d5 |
|
|
|
| PROTAC CB1R Degrader-1 |
|
|
|
| PSB-CB5 |
|
|
98.3% |
| PSB-KD107 |
|
|
|
| PSB-KK1415 |
|
|
99.92% |
| PSB-KK1445 |
|
|
99.80% |
| PSB-SB-1203 |
|
|
|
| PSB-SB-487 |
|
|
98.01% |
| PSB-SB1202 |
|
|
99.48% |
| PSNCBAM-1 |
|
|
99.48% |
| PTI-1 |
|
|
|
| R-2 Methanandamide |
|
|
|
| RD-pepcan-11 |
|
|
|
| rel-O-2050 |
|
|
|
| Rimonabant carboxylic acid |
|
|
99.91% |
| RNB-61 |
|
|
|
| Rosonabant |
|
|
99.68% |
| RTI-371 |
|
|
|
| RTICBM-189 |
|
|
99.73% |
| RTICBM-74 |
|
|
|
| RVD-Hpα |
|
|
|
| RVD-Hpα TFA |
|
|
98.92% |
| S-Methoprene |
|
|
98.58% |
| S-1 Methanandamide |
|
|
98.0% |
| S-2 Methanandamide |
|
|
|
| S-777469 |
|
|
98.19% |
| SAD448 |
|
|
|
| SCH 336 |
|
|
98.63% |
| SER-601 |
|
|
|
| SMM-189 |
|
|
|
| SR144528 |
|
|
99.02% |
| Surinabant |
|
|
98.00% |
| Synaptamide |
|
|
99.0% |
| Synaptamide-d4 |
|
|
|
| TC-C 14G |
|
|
|
| Tedalinab |
|
|
99.84% |
| Tetrahydrocannabiphorol |
|
|
|
| TM38837 |
|
|
|
| Tocrifluor 1117 |
|
|
|
| Tricosanoyl ethanolamide |
|
|
|
| TRPM8 antagonist 4 |
|
|
|
| TRPM8 antagonist 4 prodrug |
|
|
|
| TRPV1/CB2 agonist 1 |
|
|
|
| UCM707 |
|
|
|
| UCM710 |
|
|
|
| URB447 |
|
|
99.5% |
| UVI3502 |
|
|
|
| Vicasinabin |
|
|
98.37% |
| Virodhamine hydrochloride |
|
|
|
| Virodhamine TFA |
|
|
|
| VSN-16 |
|
|
99.31% |
| VU6077967 |
|
|
|
| ZCZ011 |
|
|
99.68% |
| Zevaquenabant |
|
|
99.64% |
| β-Caryophyllene-13C,d2 |
|
|
|
| β-Caryophyllene-d2 |
|
|
94.21% |
| β-Caryophyllene |
|
|
99.75% |
| γ-Linolenoyl monoethanolamide |
|
|
|
| Δ4(8)-iso-THC |
|
|
|
| Δ4-Iso-THC |
|
|
|
| Δ8-iso-THC |
|
|
|
| Δ8-Tetrahydrocannabivarin |
|
|
|
| Δ8-THC Glucuronide |
|
|
|
| Δ8-THC methyl ether |
|
|
|
| Δ8-THC-ethyl |
|
|
|
| Δ8-THCB |
|
|
|
| Δ8-THCBA-A |
|
|
|
| Δ8-THCP |
|
|
|
| Δ8-THCPA-A |
|
|
|
| Δ9-Tetrahydrocannabinolic acid |
|
|
|
| Δ9-Tetrahydrocannabiorcol |
|
|
|
| Δ9-THCB |
|
|
|
| Δ9-THCBA-A |
|
|
|
| Δ9-THCH |
|
|
|
| Δ9-THCP acetate |
|
|
|
| Ibipinabant |
|
|
99.90% |
| Rimonabant |
|
|
99.52% |
| Rimonabant-d10 |
|
|
|
| BML-190 |
|
|
99.53% |
| Tetrahydromagnolol |
|
|
99.89% |
| Cannabicitran |
|
|
|
| Otenabant |
|
|
99.63% |
| Otenabant Hydrochloride |
|
|
|
| Pregnenolone |
|
|
99.85% |
| Pregnenolone-13C2,d2 |
|
|
|
| Pregnenolone-d4 |
|
|
|
| Pregnenolone (Standard) |
|
|
99.91% |
| Pregnenolone-d4-1 |
|
|
99.34% |
| Pregnenolone-d6 |
|
|
|
| Pregnenolone monosulfate |
|
|
99.96% |
| Pregnenolone monosulfate sodium |
|
|
99.96% |
| Pregnenolone monosulfate-d4 sodium |
|
|
99.8% |
| Olivetol |
|
|
99.84% |
| Olivetol-d9 |
|
|
|
| Taranabant |
|
|
99.95% |
| Taranabant ((1R,2R)stereoisomer) |
|
|
99.94% |
| Taranabant racemate |
|
|
99.82% |
| Yangonin |
|
|
99.65% |
| Yangonin-d3 |
|
|
|
| Rimonabant Hydrochloride |
|
|
99.31% |
| Rimonabant-d10 hydrochloride |
|
|
|
| Voacamine |
|
|
99.64% |
| Leelamine hydrochloride |
|
|
98.10% |
| ACEA |
|
|
96.2% |
| Anandamide |
|
|
98.43% |